Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(783)
- Cyclic GMP-AMP Synthase(6)
- TLR(124)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(69)
- AP-1(14)
- KEAP1-Nrf2(58)
- NOD1(1)
- NF-κB(317)
- Interleukin Related(314)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(43)
- CD73(17)
- Complement System(75)
- Galectin(13)
- IFNAR(63)
- NO Synthase(96)
- NOD-like Receptor (NLR)(70)
- STING(120)
- Reactive Oxygen Species(526)
- FKBP(16)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(8)
- CD20(14)
- CD28(4)
- PSMA(15)
- FAP(24)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(4)
- Hapten(1)
- Nectin-4(3)
- DOCK(4)
- MHC(12)
- Transmembrane Glycoprotein(33)
- TREM receptor(12)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(12)
- IKZF Family(5)
- C-type Lectin-like Receptors (CTLRs)(9)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4674)
- GC79348RadanstobartCAS: 3064483-12-8Purity: >99.00%
Radanstobart (HFB-200603) is a humanized monoclonal antibody targeting CD272 with antitumor activity.
- GC79349Anti-CD80 Antibody (TKMF5)Purity: >96.50%
Anti-CD80 Antibody (TKMF5) is an antibody against human CD80.
- GC793532,4-Dinitrobenzenesulfonic acidCAS: 89-02-1Purity: >98.00%
2,4-Dinitrobenzenesulfonic acid (Compound 3) is a ecto-5'-Nucleotidase ( CD73 ) inhibitor with a K i value of 63 μM for human and 144 μM for rat.
- GC79355SAR-443809Purity: >97.00%
SAR-443809 is a monoclonal antibody targeting complement factor Bb that inhibits the alternative complement pathway.
- GC79356AscuprubartCAS: 3056020-15-3Purity: >97.50%
Ascuprubart is an anti-human monoclonal antibody targeting Complement C5.
- GC79357ANX-M1 (Human IgG1)Purity: >99.00%
ANX-M1 is a blood-brain barrier-permeable anti- C1q antibody.
- GC79360Pulchinenoside JCAS: 1476801-10-1Purity: >98.00%
Pulchinenoside J is a lupane-type triterpenoid saponin and a complement system inhibitor that acts via the classical pathway.
- GC79361VonaprumentCAS: 3050549-24-8Purity: >98.00%
Vonaprument (ANX-007) is an intravitreally injected C1q antibody fragment (with a molecular weight of approximately 48 kDa) and a human monoclonal antibody.
- GC79366IptocigistatCAS: 3047739-67-0Purity: >98.00%
Iptocigistat (Iptocigistatum) is a cyclic GMP-AMP synthase ( cGAS ) inhibitor.
- GC79371FAPI-800CWPurity: >99.00%
FAPI-800CW is a near-infrared (NIR) fluorescent-labeled fibroblast activation protein ( FAP ) inhibitor.
- GC79372Rosnilimab (Mouse IgG2a)Purity: >98.00%
Rosnilimab (Mouse IgG2a ) is a mouse-derived IgG2a antibody, Rosnilimab.
- GC79375FrenlosirsenCAS: 2304711-81-5Purity: >96.00%
Frenlosirsen (ION-935918; ION251) is an antisense oligonucleotide and also an IRF4 inhibitor.
- GC79376Frenlosirsen scrambled controlPurity: >98.00%
Frenlosirsen scrambled control is a scrambled control antisense oligonucleotide of Frenlosirsen with a scrambled sequence in the target binding region.
- GC79377Frenlosirsen sodiumCAS: 2304711-82-6Purity: >96.00%
Frenlosirsen sodium (ION-935918 sodium; ION251 sodium) is an antisense oligonucleotide and also an IRF4 inhibitor.
- GC79378Peginterferon alfa-2aCAS: 198153-51-4Purity: >98.00%
Peginterferon alfa-2a (Ro 25-8310/000) is a 40 kDa branched pegylated IFN alfa-2a with antiviral and immunomodulatory activities.
- GC79379Anti-Mouse IFN Beta Antibody (MIB-5E9.1)Purity: >96.00%
Anti-Mouse IFN Beta Antibody (MIB-5E9.1) is an antibody targeting mouse IFN-β. Anti-Mouse IFN Beta Antibody (MIB-5E9.1) blocks the IFN-β signaling pathway, abolishes LPS-induced upregulation of B7H1 and GITRL in dendritic cells, restores dendritic cell-dependent T cell proliferation impaired by LPS exposure, and reverses LPS-induced upregulation of PD-1 on splenic T cells.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79347 | AL044 | - | >97.00% | |
AL044 is an antibody targeting MS4A family proteins. | ||||
| GC79348 | Radanstobart | 3064483-12-8 | >99.00% | |
Radanstobart (HFB-200603) is a humanized monoclonal antibody targeting CD272 with antitumor activity. | ||||
| GC79349 | Anti-CD80 Antibody (TKMF5) | - | >96.50% | |
Anti-CD80 Antibody (TKMF5) is an antibody against human CD80. | ||||
| GC79353 | 2,4-Dinitrobenzenesulfonic acid | 89-02-1 | >98.00% | |
2,4-Dinitrobenzenesulfonic acid (Compound 3) is a ecto-5'-Nucleotidase ( CD73 ) inhibitor with a K i value of 63 μM for human and 144 μM for rat. | ||||
| GC79354 | YL0441 | - | >98.50% | |
YL0441 is an inhibitor of ΔFOSB/JUND heterodimers and ΔFOSB homomultimers, with IC 50 values of 13.7 μM and 12.3 μM, respectively. | ||||
| GC79355 | SAR-443809 | - | >97.00% | |
SAR-443809 is a monoclonal antibody targeting complement factor Bb that inhibits the alternative complement pathway. | ||||
| GC79356 | Ascuprubart | 3056020-15-3 | >97.50% | |
Ascuprubart is an anti-human monoclonal antibody targeting Complement C5. | ||||
| GC79357 | ANX-M1 (Human IgG1) | - | >99.00% | |
ANX-M1 is a blood-brain barrier-permeable anti- C1q antibody. | ||||
| GC79358 | Lexucitug | 3058391-51-5 | >98.00% | |
Lexucitug (DCSZ-11) is a humanized monoclonal antibody targeting CD93. | ||||
| GC79359 | RPARPAR acetate | - | >99.00% | |
RPARPAR acetate is a CendR tumor-penetrating peptide. | ||||
| GC79360 | Pulchinenoside J | 1476801-10-1 | >98.00% | |
Pulchinenoside J is a lupane-type triterpenoid saponin and a complement system inhibitor that acts via the classical pathway. | ||||
| GC79361 | Vonaprument | 3050549-24-8 | >98.00% | |
Vonaprument (ANX-007) is an intravitreally injected C1q antibody fragment (with a molecular weight of approximately 48 kDa) and a human monoclonal antibody. | ||||
| GC79362 | Anti-CD55 Antibody | - | >99.50% | |
Anti-CD55 Antibody is an anti- CD55 antibody. | ||||
| GC79366 | Iptocigistat | 3047739-67-0 | >98.00% | |
Iptocigistat (Iptocigistatum) is a cyclic GMP-AMP synthase ( cGAS ) inhibitor. | ||||
| GC79368 | 4L2-P13D | - | >98.00% | |
4L2-P13D is an IL-11 antagonist with an IC 50 of 2.8 μM. | ||||
| GC79369 | L-Ala-BPA | 2941355-27-5 | >98.00% | |
L-Ala-BPA is a boron delivery agent. | ||||
| GC79371 | FAPI-800CW | - | >99.00% | |
FAPI-800CW is a near-infrared (NIR) fluorescent-labeled fibroblast activation protein ( FAP ) inhibitor. | ||||
| GC79372 | Rosnilimab (Mouse IgG2a) | - | >98.00% | |
Rosnilimab (Mouse IgG2a ) is a mouse-derived IgG2a antibody, Rosnilimab. | ||||
| GC79373 | FK3453 | 560111-91-3 | >99.50% | |
FK3453 is a dual adenosine A1/A2 inhibitor and a TSLP inhibitor. | ||||
| GC79375 | Frenlosirsen | 2304711-81-5 | >96.00% | |
Frenlosirsen (ION-935918; ION251) is an antisense oligonucleotide and also an IRF4 inhibitor. | ||||
| GC79376 | Frenlosirsen scrambled control | - | >98.00% | |
Frenlosirsen scrambled control is a scrambled control antisense oligonucleotide of Frenlosirsen with a scrambled sequence in the target binding region. | ||||
| GC79377 | Frenlosirsen sodium | 2304711-82-6 | >96.00% | |
Frenlosirsen sodium (ION-935918 sodium; ION251 sodium) is an antisense oligonucleotide and also an IRF4 inhibitor. | ||||
| GC79378 | Peginterferon alfa-2a | 198153-51-4 | >98.00% | |
Peginterferon alfa-2a (Ro 25-8310/000) is a 40 kDa branched pegylated IFN alfa-2a with antiviral and immunomodulatory activities. | ||||
| GC79379 | Anti-Mouse IFN Beta Antibody (MIB-5E9.1) | - | >96.00% | |
Anti-Mouse IFN Beta Antibody (MIB-5E9.1) is an antibody targeting mouse IFN-β. Anti-Mouse IFN Beta Antibody (MIB-5E9.1) blocks the IFN-β signaling pathway, abolishes LPS-induced upregulation of B7H1 and GITRL in dendritic cells, restores dendritic cell-dependent T cell proliferation impaired by LPS exposure, and reverses LPS-induced upregulation of PD-1 on splenic T cells. | ||||
